Continuation of dual anti-platelet therapy after drug-eluting stents in primary angioplasty beyond 12 months [v1; ref status: indexed, http://f1000r.es/TbAhzm]

Abstract

In this correspondence we discuss the results of the meta-analysis by De Luca et al. (2012) in the Archives of Internal Medicine which found that late myocardial reinfarction and stent thrombosis is more common in drug-eluting stents than in bare-metal stents. We discuss the clinical implications of this paper for dual anti-platelet therapy which did not receive sufficient attention in the original publication and the accompanying editorial.

Keywords

• Cardiovascular Medicine in Anesthesia: Clinical Science
• Cardiovascular Pharmacology
• Coronary Artery Disease